Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19

The use of convalescent plasma in the treatment of COVID-19 may lead to a milder course of infection and has been associated with improved outcomes. Determining optimal treatments in high risk populations is crucial, as is the case in those with hematological malignancies. We analyzed a cohort of 23...

Full description

Bibliographic Details
Main Authors: Monika Maria Biernat, Anna Kolasińska, Jacek Kwiatkowski, Donata Urbaniak-Kujda, Paweł Biernat, Justyna Janocha-Litwin, Małgorzata Szymczyk-Nużka, Dawid Bursy, Elżbieta Kalicińska, Krzysztof Simon, Grzegorz Mazur, Tomasz Wróbel
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Viruses
Subjects:
COVID-19
convalescent plasma
hematological malignancies
Online Access:https://www.mdpi.com/1999-4915/13/3/436

Similar Items

Similar Items